Investors who purchased Wix.com Ltd. shares between February 19, 2025, and May 12, 2026, face an approaching September 22, 2026, deadline to seek lead plaintiff status in a class action lawsuit. Schall, Brown & Schwartz LLP is representing shareholders alleging the company misled the market regarding its AI business operations.
A new class action lawsuit alleges that Capricor Therapeutics misled shareholders by altering clinical trial statistical plans for its drug, Deramiocel, without prior FDA approval. The litigation, filed in federal court, centers on claims that the company disseminated false information between December 17, 2025, and July 26, 2026.
Shareholders who acquired Pentair plc stock between April 28 and July 14, 2026, face a critical October 2 deadline to join a class action lawsuit. The litigation alleges the company issued materially misleading statements regarding financial performance amid a significant destocking of its pool channel products.
A class action lawsuit has been filed against EquipmentShare.com Inc. following allegations that the company obscured related-party transactions. Shareholders who acquired EQPT stock between January 23 and June 23, 2026, are now being urged to evaluate their legal standing before the September 21 filing deadline.
A federal class action lawsuit alleges PROCEPT BioRobotics misled investors by inflating revenue through aggressive discounting tactics. The complaint claims the company pulled sales forward from future periods, resulting in a significant inventory glut that rendered its public financial disclosures false and materially misleading throughout the two-year class period.
A class action lawsuit alleges that Cogent Communications Holdings, Inc. misled shareholders by inflating its backlog with unlikely revenue-generating orders. The litigation, centered on claims of false statements made between February 2024 and May 2026, invites investors to seek potential recovery for losses incurred during the period.
Dizal will present new clinical data for its EGFR inhibitor ZEGFROVY at the 2026 World Conference on Lung Cancer in Seoul, highlighting its potential in early-stage disease and combination therapies. The findings arrive as the company moves to expand the drug's reach beyond its current status as a later-line treatment.
With a strategic push into the premium display market, Hisense has released its 2026 E8S ULED MiniLED lineup, debuting on Amazon with aggressive launch pricing. The series targets a broad audience by blending high-end gaming specifications with cinema-grade visual standards and a proprietary AI-driven processing engine.
In Brewster, Washington, a remote medical facility is challenging the trend of rural hospital closures by maintaining comprehensive, 24/7 care. An upcoming segment of the Public Television series "All Access hosted by Andy Garcia" documents how this independent hub serves its community without the backing of a large urban system.
Investors holding First Solar, Inc. securities are facing an August 24, 2026, deadline to join a class action lawsuit against the company. The litigation concerns allegations that the manufacturer misled shareholders regarding its capacity to navigate international trade tariffs and relocate operations from Southeast Asia to the United States.
3SBio reported a robust first half of 2026, with adjusted operating net profit climbing 26.5% to RMB 1.44 billion. The company accelerated its international footprint, fueled by a 43% surge in overseas sales and the rapid global clinical progression of its flagship anti-PD-1/VEGF bispecific antibody, SSGJ-707.
RayNeo is bifurcating its augmented reality portfolio, moving away from universal devices toward specialized hardware. The company announced the upcoming September 4 launch of the RayNeo iO, an ambient productivity assistant, and the RayNeo GT Series, a high-fidelity spatial cinema system designed to capture distinct segments of the consumer market.
With physical therapist demand projected to jump 31 percent by 2032, Southern California University of Health Sciences is launching an accelerated, two-year Doctor of Physical Therapy program in Tempe. This online-hybrid expansion aims to address the nationwide shortage by shortening the traditional three-year degree timeline for students in the Phoenix Metro area.
The Western Maryland Scenic Railroad has become the nation’s first heritage rail operator to earn Certified Autism Center status, effectively merging historic preservation with modern inclusivity. This transformation will be the subject of an upcoming segment on the public television educational series "All Access," hosted by actor Andy Garcia.
At the 2026 World Robot Conference in Beijing, Zoomlion Heavy Industry is shifting the focus of robotics from laboratory research to factory floors. The company is showcasing a suite of humanoid and quadrupedal machines alongside specialized software platforms designed to replace fixed-program automation with autonomous, self-correcting manufacturing units.
Commanding a 23.7% share of the global consumer AR market, RayNeo is bifurcating its hardware strategy to address two distinct user needs: ambient daily intelligence and high-fidelity entertainment. The company officially debuts its new product lines, the iO Smart Glasses and the cinema-grade GT Series, on September 4, 2026.
With FDA approval for its RefluxStop device now secured, Vaduz-based Implantica is shifting its focus toward a full-scale U.S. market entry. The company reported a 60% surge in second-quarter sales, bolstered by new clinical data and a growing network of European Centers of Excellence.
With FDA approval for its RefluxStop device now secured, Vaduz-based Implantica is pivoting toward a major American expansion. The company reported a 66% surge in second-quarter net sales to 717,000 euros, bolstered by a 60% increase in European sales and the publication of a significant 602-patient safety study.
Investors who purchased Futu Holdings Limited securities between May 24, 2023, and May 27, 2026, face an August 25, 2026, deadline to participate in a class action lawsuit. The litigation, led by Schall Brown & Schwartz LLP, alleges the company misled the market regarding its compliance with Chinese regulatory standards.
Investors who purchased Hub Group stock between April 28, 2023, and May 11, 2026, face an August 28 deadline to join a class action lawsuit. The litigation alleges that the logistics firm violated federal securities laws by issuing a series of materially misleading financial statements regarding revenue and operating income.
Investors in First Solar are facing a looming August 24 deadline to join a class action lawsuit alleging the company misled the market regarding its manufacturing shift. The complaint centers on claims that the firm exaggerated its capacity to relocate operations from Asia to the United States amid tariff pressure.
Investors who purchased Peabody Energy Corporation stock between October 14, 2024, and May 4, 2026, face an August 24, 2026, deadline to join a class action lawsuit. The litigation, led by Schall Brown & Schwartz LLP, alleges the company misled shareholders regarding the development status of its Centurion mine project.
Investors who held Peabody Energy Corporation stock between October 2024 and May 2026 are facing a critical August 24 deadline to join a class action lawsuit. The litigation targets the coal producer for allegedly misleading the market regarding production timelines and operational setbacks at its Centurion mine site.
China's National Medical Products Administration has granted clinical trial clearance for AK157D1, an experimental antibody-drug conjugate developed by Akeso. The approval marks a significant expansion of the company’s oncology pipeline, allowing researchers to initiate Phase I testing of the drug in patients suffering from advanced malignant solid tumors.
To commemorate its 50th anniversary, New Brunswick-based Next Level Performance expanded its annual community outreach, merging its signature HOPE Week with a new initiative dubbed 50 Days of Giving Back. The campaign emphasizes the firm’s long-standing corporate mandate to prioritize social impact alongside its employee engagement business.
Tokyo-based TIER IV is shifting its patent strategy by joining the Open Invention Network 2.0. The developer of the Autoware autonomous driving platform aims to mitigate legal risks for automakers and suppliers, fostering a more secure environment for the adoption of open-source software within the global automotive industry.
As the total on-chain real-world asset market surges toward a $38 billion valuation, trading platform BiFu is shifting its strategy from simple spot trading to institutional-grade asset management. By integrating managed funds and tokenized private equity, the exchange aims to provide retail users with access to previously unreachable investment classes.
The U.S. Food and Drug Administration has granted premarket approval to Implantica for its RefluxStop device, marking a significant entry into the world's largest medical device market. The implant offers a non-constrictive alternative for the 78 million Americans suffering from gastroesophageal reflux disease.
The U.S. Food and Drug Administration has granted premarket approval to Implantica’s RefluxStop, an implantable device designed to treat gastroesophageal reflux disease. The decision clears the Liechtenstein-based medtech firm to enter the American market, targeting a patient population estimated at 78 million people suffering from chronic acid reflux.
A network security failure at Apple American Group has prompted a formal investigation by the law firm Edelson Lechtzin LLP. Unauthorized actors gained access to company servers over a two-day period in April, potentially exposing the personal sensitive data of current and former employees to significant privacy risks.
